All Square Wealth Management LLC Anavex Life Sciences Corp. Transaction History

All Square Wealth Management LLC

$169 Million
Q1 2024

A detailed history of All Square Wealth Management LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, All Square Wealth Management LLC holds 51,966 shares of AVXL stock, worth $214,099. This represents 0.16% of its overall portfolio holdings.

Number of Shares

51,966

Previous 53,456 2.79%

Holding current value

$214,099

Previous $497,000 46.88%

% of portfolio

0.16%

Previous 0.31%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$4.55 - $6.75 $6,779 - $10,057	-1,490 Reduced 2.79%	51,966 $264,000
Q4 2023 Feb 14, 2024	SELL	$5.04 - $9.95 $7,560 - $14,924	-1,500 Reduced 2.73%	53,456 $497,000
Q3 2023 Nov 27, 2023	SELL	$6.55 - $9.37 $65,500 - $93,699	-10,000 Reduced 15.4%	54,956 $359,000
Q2 2023 Aug 08, 2023	SELL	$7.66 - $9.5 $7,660 - $9,500	-1,000 Reduced 1.52%	64,956 $528,000
Q1 2022 May 04, 2022	BUY	$9.74 - $17.69 $15,632 - $28,392	1,605 Added 2.49%	65,956 $812,000

Q4 2021 Feb 08, 2022	BUY	$16.88 - $23.31 $21,370 - $29,510	1,266 Added 2.01%	64,351 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$16.82 - $25.75 $16,820 - $25,750	1,000 Added 1.61%	63,085 $1.13 Million
Q2 2021 Aug 13, 2021	BUY	$10.16 - $28.86 $508 - $1,443	50 Added 0.08%	62,085 $1.42 Million
Q1 2021 May 11, 2021	BUY	$5.17 - $16.13 $83,521 - $260,580	16,155 Added 35.21%	62,035 $927,000
Q4 2020 Feb 09, 2021	BUY	$4.01 - $7.58 $7,322 - $13,841	1,826 Added 4.14%	45,880 $248,000
Q3 2020 Nov 16, 2020	BUY	$3.8 - $5.0 $51,923 - $68,320	13,664 Added 44.96%	44,054 $200,000
Q2 2020 Aug 11, 2020	SELL	$2.62 - $5.2 $3,109 - $6,172	-1,187 Reduced 3.76%	30,390 $150,000
Q1 2020 May 12, 2020	SELL	$2.38 - $5.81 $21,055 - $51,401	-8,847 Reduced 21.89%	31,577 $99,000
Q3 2019 Nov 06, 2019	BUY	$2.22 - $3.9 $9,812 - $17,238	4,420 Added 12.28%	40,424 $128,000
Q2 2019 Aug 13, 2019	BUY	$2.75 - $3.7 $9,938 - $13,371	3,614 Added 11.16%	36,004 $121,000
Q1 2019 May 07, 2019	BUY	$1.68 - $3.42 $26,980 - $54,925	16,060 Added 98.35%	32,390 $99,000
Q3 2017 Nov 06, 2017	BUY	$3.42 - $4.87 $55,848 - $79,527	16,330	16,330 $68,000

Others Institutions Holding AVXL

# of Institutions

159

Shares Held

31.6M

Call Options Held

910K

Put Options Held

1.35M

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $321M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of All Square Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on All Square Wealth Management LLC with notifications on news.

Account

All Square Wealth Management LLC Anavex Life Sciences Corp. Transaction History